FRCPath Haem Part 1 MCQ-Oncology 118

A patient receiving glofitamab develops a persistent fever of 38.5 °C and hypotension 12 hours after first step-up dose. What is the most appropriate next step?

• Continue Glofitamab and give IV Fluids with Antibiotics
• Stop Glofitamab permanently and switch to CAR T-cell therapy
• Stop Glofitamab and monitor
• Stop Glofitamab and give Tocilizumab

See All Options

Want to read more?

Subscribe to hematomorph.com to keep reading this exclusive post.

Subscribe Now